A coalition of state attorneys general, including those in Pennsylvania and New Jersey, has reached agreements with two ...

Premiums for Medicare Part D, which covers prescription drugs, will be rising by as much as $35 per month for many Long ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), ...

Walgreens has agreed to pay $100 million to settle a proposed class action lawsuit accusing it of fraudulently overcharging ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

When patents for name brand medicines expire, the price of that medicine drops significantly as generic versions enter the market, but that process can take a while.

Heritage Pharmaceuticals and Apotex will pay $49.1 million in a settlement with Pennsylvania, New Jersey and other states.

About 18.7 million people will save $7.4 billion next year alone thanks to changes to Medicare drug benefits, the ...

Business owners in downtown Fredericton say they are increasingly frustrated with a rise in break-ins, theft, vandalism, open ...

The influence of AI in drug development has gained such importance that it has been termed a revolution. Let’s explore how ...

The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...